{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:48:28Z","timestamp":1792439308307,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T00:00:00Z","timestamp":1497916800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000863","name":"Bowel Disease Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10151-017-1647-3","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T08:53:37Z","timestamp":1497948817000},"page":"501-519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prognostic factors affecting outcomes in fistulating perianal Crohn\u2019s disease: a systematic review"],"prefix":"10.1007","volume":"21","author":[{"given":"G. C.","family":"Braithwaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,20]]},"reference":[{"key":"1647_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel J-F (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749\u2013753. doi:\n                        10.1136\/gut.2005.082909","journal-title":"Gut"},{"key":"1647_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3748\/wjg.v21.i5.1394","volume":"21","author":"M Marzo","year":"2015","unstructured":"Marzo M (2015) Management of perianal fistulas in Crohn\u2019s disease: an up-to-date review. World J Gastroenterol 21:1394. doi:\n                        10.3748\/wjg.v21.i5.1394","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1647_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/codi.13462","volume":"19","author":"MJ Lee","year":"2017","unstructured":"Lee MJ, Heywood N, Sagar PM et al (2017) Surgical management of fistulating perianal Crohn\u2019s disease\u2014a UK survey. Colorectal Dis 19(3):266\u2013273","journal-title":"Colorectal Dis"},{"key":"1647_CR4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA et al (2014) A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease. Gut 63:1381\u20131392. doi:\n                        10.1136\/gutjnl-2013-306709","journal-title":"Gut"},{"key":"1647_CR5","doi-asserted-by":"publisher","first-page":"g6670","DOI":"10.1136\/bmj.g6670","volume":"349","author":"R Kalla","year":"2014","unstructured":"Kalla R, Ventham NT, Satsangi J, Arnott IDR (2014) Crohn\u2019s disease. BMJ 349:g6670. doi:\n                        10.1136\/bmj.g6670","journal-title":"BMJ"},{"key":"1647_CR6","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1365-2036.2010.04303.x","volume":"31","author":"BG Feagan","year":"2010","unstructured":"Feagan BG, Reilly MC, Gerlier L et al (2010) Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn\u2019s disease in the precise 2 study. Aliment Pharmacol Ther 31:1276\u20131285. doi:\n                        10.1111\/j.1365-2036.2010.04303.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR7","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1365-2036.2010.04466.x","volume":"32","author":"S Lichtiger","year":"2010","unstructured":"Lichtiger S, Binion DG, Wolf DC et al (2010) The CHOICE trial: Adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohns disease who failed prior infliximab therapy. Aliment Pharmacol Ther 32:1228\u20131239. doi:\n                        10.1111\/j.1365-2036.2010.04466.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bpg.2014.04.011","volume":"28","author":"I Molendijk","year":"2014","unstructured":"Molendijk I, Peeters KCMJ, Baeten CIM et al (2014) Improving the outcome of fistulising Crohn\u2019s disease. Best Pract Res Clin Gastroenterol 28:505\u2013518","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1647_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.crohns.2011.09.001","volume":"6","author":"A Lahat","year":"2012","unstructured":"Lahat A, Assulin Y, Beer-Gabel M, Chowers Y (2012) Endoscopic ultrasound for perianal Crohn\u2019s disease: disease and fistula characteristics, and impact on therapy. J Crohns Colitis 6:311\u2013316","journal-title":"J Crohns Colitis"},{"key":"1647_CR10","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s10620-013-2830-7","volume":"58","author":"M Chaparro","year":"2013","unstructured":"Chaparro M, Zanotti C, Burgue\u00f1o P et al (2013) Health care costs of complex perianal fistula in Crohn\u2019s disease. Dig Dis Sci 58:3400\u20133406. doi:\n                        10.1007\/s10620-013-2830-7","journal-title":"Dig Dis Sci"},{"key":"1647_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/codi.12790","volume":"16","author":"J Tiernan","year":"2014","unstructured":"Tiernan J, Cook A, Geh I et al (2014) Use of a modified Delphi approach to develop research priorities for the association of coloproctology of Great Britain and Ireland. Color Dis 16:965\u2013970. doi:\n                        10.1111\/codi.12790","journal-title":"Color Dis"},{"key":"1647_CR12","unstructured":"IBD Priority Setting Partnership (2015) Inflammatory bowel disease (IBD) research priorities from IBD priority-setting partnership. James Lind Alliance, Southampton, London"},{"key":"1647_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359.Association","volume":"47","author":"JZ Liu","year":"2016","unstructured":"Liu JZ, Van Sommeren S, Huang H et al (2016) Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47:979\u2013986. doi:\n                        10.1038\/ng.3359.Association","journal-title":"Nat Genet"},{"key":"1647_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","volume":"387","author":"I Cleynen","year":"2016","unstructured":"Cleynen I, Boucher G, Jostins L et al (2016) Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387:156\u2013167. doi:\n                        10.1016\/S0140-6736(15)00465-1","journal-title":"Lancet"},{"key":"1647_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312518","author":"M Weiser","year":"2016","unstructured":"Weiser M, Simon JM, Kochar B et al (2016) Molecular classification of Crohn\u2019s disease reveals two clinically relevant subtypes. Gut. doi:\n                        10.1136\/gutjnl-2016-312518","journal-title":"Gut"},{"key":"1647_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.crohns.2014.02.002","volume":"8","author":"GC Parkes","year":"2014","unstructured":"Parkes GC, Whelan K, Lindsay JO (2014) Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 8:717\u2013725. doi:\n                        10.1016\/j.crohns.2014.02.002","journal-title":"J Crohns Colitis"},{"key":"1647_CR17","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1136\/gutjnl-2013-306226","volume":"63","author":"CR Hedin","year":"2014","unstructured":"Hedin CR, McCarthy NE, Louis P et al (2014) Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn\u2019s disease and their unaffected siblings. Gut 63:1578\u20131586. doi:\n                        10.1136\/gutjnl-2013-306226","journal-title":"Gut"},{"key":"1647_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312135","author":"F Imhann","year":"2016","unstructured":"Imhann F, Vich Vila A, Bonder MJ et al (2016) Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. doi:\n                        10.1136\/gutjnl-2016-312135","journal-title":"Gut"},{"key":"1647_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4291\/wjgp.v5.i3.205","volume":"5","author":"M Scharl","year":"2014","unstructured":"Scharl M, Rogler G (2014) Pathophysiology of fistula formation in Crohn\u2019s disease. World J Gastrointest Pathophysiol 5:205\u2013212. doi:\n                        10.4291\/wjgp.v5.i3.205","journal-title":"World J Gastrointest Pathophysiol"},{"key":"1647_CR20","doi-asserted-by":"publisher","first-page":"e5595","DOI":"10.1136\/bmj.e5595","volume":"346","author":"H Hemingway","year":"2013","unstructured":"Hemingway H, Croft P, Perel P et al (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 346:e5595. doi:\n                        10.1136\/bmj.e5595","journal-title":"BMJ"},{"key":"1647_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, van der Windt DA, Cartwright JL et al (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280\u2013286. doi:\n                        10.7326\/0003-4819-158-4-201302190-00009","journal-title":"Ann Intern Med"},{"key":"1647_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/gut.37.5.696","volume":"37","author":"F Makowiec","year":"1995","unstructured":"Makowiec F, Jehle EC, Starlinger M (1995) Clinical course of perianal fistulas in Crohn\u2019s disease. Gut 37:696\u2013701. doi:\n                        10.1136\/gut.37.5.696","journal-title":"Gut"},{"key":"1647_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S et al (1999) Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med 340:1398\u20131405. doi:\n                        10.1056\/NEJM199905063401804","journal-title":"N Engl J Med"},{"key":"1647_CR24","doi-asserted-by":"publisher","DOI":"10.1046\/j.0269-2813.2003.01561.x","author":"S Bell","year":"2003","unstructured":"Bell S, Williams A, Wiesel P et al (2003) The clinical course of fistulating Crohn\u2019s disease. Aliment Pharmacol Ther. doi:\n                        10.1046\/j.0269-2813.2003.01561.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00384-009-0638-x","volume":"24","author":"T L\u00f6ffler","year":"2009","unstructured":"L\u00f6ffler T, Welsch T, M\u00fchl S et al (2009) Long-term success rate after surgical treatment of anorectal and rectovaginal fistulas in Crohn\u2019s disease. Int J Colorectal Dis 24:521\u2013526. doi:\n                        10.1007\/s00384-009-0638-x","journal-title":"Int J Colorectal Dis"},{"key":"1647_CR26","doi-asserted-by":"crossref","unstructured":"Luna-Chadid M, P\u00e9rez Calle JL, Mendoza JL et al (2004) Predictors of response to infliximab in patients with fistulizing Crohn\u2019s disease. Rev Esp Enferm Dig 96:379-81\u20134","DOI":"10.4321\/S1130-01082004000600003"},{"key":"1647_CR27","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","volume":"50","author":"WB Gaertner","year":"2007","unstructured":"Gaertner WB, Decanini A, Mellgren A et al (2007) Does infliximab infusion impact results of operative treatment for Crohn\u2019s perianal fistulas? Dis Colon Rectum 50:1754\u20131760","journal-title":"Dis Colon Rectum"},{"key":"1647_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1572-0241.2007.01741.x","volume":"103","author":"S Angelberger","year":"2008","unstructured":"Angelberger S, Reinisch W, Dejaco C et al (2008) NOD2\/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn\u2019s disease. Am J Gastroenterol 103:1197\u20131202. doi:\n                        10.1111\/j.1572-0241.2007.01741.x","journal-title":"Am J Gastroenterol"},{"key":"1647_CR29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco C, Harrer M, Waldhoer T et al (2003) Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn\u2019s disease. Aliment Pharmacol Ther 18:1113\u20131120","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1067\/msy.2000.108779","volume":"128","author":"F Michelassi","year":"2000","unstructured":"Michelassi F, Melis M, Rubin M, Hurst RD (2000) Surgical treatment of anorectal complications in Crohn\u2019s disease. Surgery 128:597\u2013603. doi:\n                        10.1067\/msy.2000.108779","journal-title":"Surgery"},{"key":"1647_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","volume":"63","author":"P Dewint","year":"2014","unstructured":"Dewint P, Hansen BE, Verhey E et al (2014) Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 63:292\u2013299. doi:\n                        10.1136\/gutjnl-2013-304488","journal-title":"Gut"},{"key":"1647_CR32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bougen","year":"2013","unstructured":"Bougen G (2013) Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab. Clin Gastroenterol Hepatol 11:975\u2013981","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1647_CR33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10620-010-1331-1","volume":"56","author":"P Freire","year":"2011","unstructured":"Freire P, Portela F, Donato MM et al (2011) CARD15 mutations and perianal fistulating Crohn\u2019s disease: correlation and predictive value of antibiotic response. Dig Dis Sci 56:853\u2013859","journal-title":"Dig Dis Sci"},{"key":"1647_CR34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/codi.12851","volume":"17","author":"A Haennig","year":"2015","unstructured":"Haennig A, Staumont G, Lepage B et al (2015) The results of seton drainage combined with anti-TNFalpha therapy for anal fistula in Crohn\u2019s disease. Colorectal Dis 17:311\u2013319","journal-title":"Colorectal Dis"},{"key":"1647_CR35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-2036.2009.04089.x","volume":"30","author":"G Bouguen","year":"2009","unstructured":"Bouguen G, Trouilloud I, Siproudhis L et al (2009) Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn\u2019s disease in patients treated with infliximab. Aliment Pharmacol Ther 30:749\u2013756","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR36","doi-asserted-by":"publisher","DOI":"10.1046\/j.0269-2813.2003.01561.x","author":"W Inson","year":"2003","unstructured":"Inson W, Mm KA, Mark S (2003) The clinical course of fistulating Crohn\u2019s disease. Aliment Pharmacol Ther. doi:\n                        10.1046\/j.0269-2813.2003.01561.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1647_CR37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/bjs.1800820509","volume":"82","author":"F Makowiec","year":"1995","unstructured":"Makowiec F, Jehle EC, Becker HD, Starlinger M (1995) Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn\u2019s disease. Br J Surg 82:603\u2013606","journal-title":"Br J Surg"},{"key":"1647_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.sla.0000186173.14696.ea","volume":"242","author":"M Alvarez-Lobos","year":"2005","unstructured":"Alvarez-Lobos M, Arostegui JI, Sans M et al (2005) Crohn\u2019s disease patients carrying Nod2\/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 242:693\u2013700. doi:\n                        10.1097\/01.sla.0000186173.14696.ea","journal-title":"Ann Surg"},{"key":"1647_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jpedsurg.2009.10.046","volume":"45","author":"M Lacher","year":"2010","unstructured":"Lacher M, Helmbrecht J, Schroepf S et al (2010) NOD2 mutations predict the risk for surgery in pediatric-onset Crohn\u2019s disease. J Pediatr Surg 45:1591\u20131597. doi:\n                        10.1016\/j.jpedsurg.2009.10.046","journal-title":"J Pediatr Surg"},{"key":"1647_CR40","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.3748\/wjg.v20.i17.5008","volume":"20","author":"M Bhullar","year":"2014","unstructured":"Bhullar M, Macrae F, Brown G et al (2014) Prediction of Crohn\u2019s disease aggression through NOD2\/CARD15 gene sequencing in an Australian cohort. World J Gastroenterol 20:5008\u20135016. doi:\n                        10.3748\/wjg.v20.i17.5008","journal-title":"World J Gastroenterol"},{"key":"1647_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/bjs.1800820112","volume":"82","author":"PJ Lunniss","year":"1995","unstructured":"Lunniss PJ, Sheffield JP, Talbot IC et al (1995) Persistence of idiopathic anal fistula may be related to epithelialization. Br J Surg 82:32\u201333. doi:\n                        10.1002\/bjs.1800820112","journal-title":"Br J Surg"},{"key":"1647_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10151-011-0803-4","volume":"16","author":"LE Mitalas","year":"2012","unstructured":"Mitalas LE, Van Onkelen RS, Monkhorst K et al (2012) Identification of epithelialization in high transsphincteric fistulas. Tech Coloproctol 16:113\u2013117. doi:\n                        10.1007\/s10151-011-0803-4","journal-title":"Tech Coloproctol"},{"key":"1647_CR43","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/00365520701320489","volume":"42","author":"K Kiehne","year":"2007","unstructured":"Kiehne K, Fincke A, Brunke G et al (2007) Antimicrobial peptides in chronic anal fistula epithelium. Scand J Gastroenterol 42:1063\u20131069. doi:\n                        10.1080\/00365520701320489","journal-title":"Scand J Gastroenterol"},{"key":"1647_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10151-015-1368-4","volume":"19","author":"GPF Selvaggi","year":"2015","unstructured":"Selvaggi GPF, Corona GGD, Delaini GRGG (2015) A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn\u2019 s disease. Tech Coloproctol 19:639\u2013651. doi:\n                        10.1007\/s10151-015-1368-4","journal-title":"Tech Coloproctol"},{"key":"1647_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12426","author":"M Lee","year":"2017","unstructured":"Lee M, Heywood N, Sagar P et al (2017) Association of coloproctology of Great Britain and Ireland consensus exercise on surgical management of fistulating perianal Crohn\u2019s disease. Color Dis. doi:\n                        10.1111\/ijlh.12426","journal-title":"Color Dis"},{"key":"1647_CR46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1072-7515(99)00092-7","volume":"189","author":"JM R\u00e9gimbeau","year":"1999","unstructured":"R\u00e9gimbeau JM, Panis Y, Marteau P et al (1999) Surgical treatment of anoperineal Crohn\u2019s disease: can abdominoperineal resection be predicted? J Am Coll Surg 189:171\u2013176","journal-title":"J Am Coll Surg"},{"key":"1647_CR47","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/BF02052593","volume":"37","author":"YP Sangwan","year":"1994","unstructured":"Sangwan YP, Rosen L, Riether RD et al (1994) Is simple fistula-in-ano simple? Dis Colon Rectum 37:885\u2013889. doi:\n                        10.1007\/BF02052593","journal-title":"Dis Colon Rectum"},{"key":"1647_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s13244-010-0022-y","volume":"1","author":"MR Torkzad","year":"2010","unstructured":"Torkzad MR, Karlbom U (2010) MRI for assessment of anal fistula. Insights Imaging 1:62\u201371. doi:\n                        10.1007\/s13244-010-0022-y","journal-title":"Insights Imaging"},{"key":"1647_CR49","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrgastro.2016.158","volume":"13","author":"KV Patel","year":"2016","unstructured":"Patel KV, Darakhshan AA, Griffin N et al (2016) Patient optimization for surgery relating to Crohn\u2019s disease. Nat Rev Gastroenterol Hepatol 13:707\u2013719. doi:\n                        10.1038\/nrgastro.2016.158","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1647_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw160","author":"M Severs","year":"2016","unstructured":"Severs M, Mangen M-JJ, van der Valk ME et al (2016) Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohn\u2019s Colitis. doi:\n                        10.1093\/ecco-jcc\/jjw160","journal-title":"J Crohn\u2019s Colitis"},{"key":"1647_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.401","author":"T Nunes","year":"2016","unstructured":"Nunes T, Etchevers MJ, Garc\u00eda-S\u00e1nchez V et al (2016) Impact of smoking cessation on the clinical course of Crohn\u2019s disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol. doi:\n                        10.1038\/ajg.2015.401","journal-title":"Am J Gastroenterol"},{"key":"1647_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"E Irvine","year":"1995","unstructured":"Irvine E (1995) Usual therapy improves perianal Crohn\u2019s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27\u201332","journal-title":"J Clin Gastroenterol"},{"key":"1647_CR53","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/sim.1190","volume":"21","author":"P Edwards","year":"2002","unstructured":"Edwards P, Clarke M, DiGuiseppi C et al (2002) Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records. Stat Med 21:1635\u20131640. doi:\n                        10.1002\/sim.1190","journal-title":"Stat Med"},{"key":"1647_CR54","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","volume":"59","author":"N Buscemi","year":"2006","unstructured":"Buscemi N, Hartling L, Vandermeer B et al (2006) Single data extraction generated more errors than double data extraction in systematic reviews. J Clin Epidemiol 59:697\u2013703. doi:\n                        10.1016\/j.jclinepi.2005.11.010","journal-title":"J Clin Epidemiol"},{"key":"1647_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ctim.2004.09.003","volume":"12","author":"C Stevinson","year":"2004","unstructured":"Stevinson C, Lawlor DA (2004) Searching multiple databases for systematic reviews: added value or diminishing returns? Complement Ther Med 12:228\u2013232. doi:\n                        10.1016\/j.ctim.2004.09.003","journal-title":"Complement Ther Med"},{"key":"1647_CR56","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jclinepi.2013.04.009","volume":"66","author":"Z Beckles","year":"2013","unstructured":"Beckles Z, Glover S, Ashe J et al (2013) Searching CINAHL did not add value to clinical questions posed in NICE guidelines. J Clin Epidemiol 66:1051\u20131057. doi:\n                        10.1016\/j.jclinepi.2013.04.009","journal-title":"J Clin Epidemiol"},{"key":"1647_CR57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5595","author":"R Riley","year":"2013","unstructured":"Riley R, Hayden J, Steyerberg E et al (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. PLoS Med. doi:\n                        10.1136\/bmj.e5595","journal-title":"PLoS Med"},{"key":"1647_CR58","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/jour-","volume":"10","author":"E Steyerberg","year":"2013","unstructured":"Steyerberg E, Moons KGM, van der Windt D et al (2013) Prognosis research strategy (PROGRESS) series 3: prognostic model research. PLoS Med 10:e1001381. doi:\n                        10.1371\/jour-","journal-title":"PLoS Med"},{"key":"1647_CR59","doi-asserted-by":"crossref","first-page":"e0116044","DOI":"10.1371\/journal.pone.0116044","volume":"10","author":"F Schnitzler","year":"2015","unstructured":"Schnitzler F, Friedrich M, Wolf C et al (2015) The NOD2 single nucleotide polymorphism rs72796353 (IVS4\u00a0+\u00a010 A\u00a0>\u00a0C) is a predictor for perianal fistulas in patients with Crohn\u2019s disease in the absence of other NOD2 mutations. PLoS ONE 10:e0116044","journal-title":"PLoS ONE"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10151-017-1647-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-017-1647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-017-1647-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T08:37:59Z","timestamp":1502267879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10151-017-1647-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1007\/s10151-017-1647-3","relation":{},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}